Open original FDA record ↗Recall record
- FDA identifier
- Z-1389-2022
- Company in FDA record
- GE Healthcare, LLC
- FDA classification date
- Jul 19, 2022
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class I
Reason stated in the source
There is a potential reversal of the O2 and air cylinder pressure transducer connections.
Source facts
- Action
- The recalling firm issued letters beginning 6/1/2022 via traceable means to the Chief of Anesthesia, Director of Biomedical/Clinical Engineering, and Health Care Administrator/Risk Manager at their consignee locations. The letter was flagged that consignees should ensure all potential users in their facility are made aware of this safety notification and the recommended actions. The letter provided the affected products, safety issue, and actions to be taken. The customer was informed they could continue to use the anesthesia system by following the instructions provided in the letter prior to use. A Medical Device Notification Acknowledgement Response form was enclosed to acknowledge receipt and understanding of the notice. The consignee was to record their anesthesia system serial number, whether it passed or failed the test, and the date of the test. The response form was supposed to be completed and returned no later than 30 days from receipt.
- Initiated
- 2022-06-01
- Root cause
- Process control
- Terminated
- 2024-10-21
- Distribution
- Worldwide Distribution. US nationwide, Australia, Austria, Belgium, Bolivia, Brazil, Canada, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Egypt, Finland, France, Germany, Greece, Hong Kong, Hungary, Iceland, India, Indonesia, Ireland, Italy, Japan, Kenya, Korea, Kuwait, Malaysia, Mexico, Montenegro, Nepal, Netherlands, New Zealand, Norway, Panama, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, United Arab Emirates, United Kingdom, and Uruguay.
- Recall number
- Z-1389-2022
- Recall status
- Terminated
- CDRH record ID
- 194361
- FDA classified
- 2022-07-19
- Recall event number
- 90424